BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 15897882)

  • 1. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
    Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
    EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.
    Puca R; Nardinocchi L; Bossi G; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Exp Cell Res; 2009 Jan; 315(1):67-75. PubMed ID: 18996371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
    EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
    Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
    Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
    Nardinocchi L; Puca R; Sacchi A; D'Orazi G
    Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
    Yamada D; Pérez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA
    Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
    Puca R; Nardinocchi L; Givol D; D'Orazi G
    Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.
    Li Q; Wang X; Wu X; Rui Y; Liu W; Wang J; Wang X; Liou YC; Ye Z; Lin SC
    Cancer Res; 2007 Jan; 67(1):66-74. PubMed ID: 17210684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2.
    Lee SW; Kim EJ; Um SJ
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1056-62. PubMed ID: 16343438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
    Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
    J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
    Dauth I; Krüger J; Hofmann TG
    Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-acetylation interplay activates p53 in response to DNA damage.
    Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
    Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arecoline-induced growth arrest and p21WAF1 expression are dependent on p53 in rat hepatocytes.
    Chou WW; Guh JY; Tsai JF; Hwang CC; Chen HC; Huang JS; Yang YL; Hung WC; Chuang LY
    Toxicology; 2008 Jan; 243(1-2):1-10. PubMed ID: 17997002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
    Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
    Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.